FierceBiotech ٢ مارس ٢٠٢٦ Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
FierceBiotech ٢٨ فبراير ٢٠٢٦ BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival
FierceBiotech ٢٧ فبراير ٢٠٢٦ Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
FierceBiotech ٢٧ فبراير ٢٠٢٦ Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
FierceBiotech ٢٧ فبراير ٢٠٢٦ FDA slams ExThera with warning letter over controversial blood filter device
FierceBiotech ٢٧ فبراير ٢٠٢٦ Generate scores largest biotech IPO since 2024 with $400M Nasdaq listing
FierceBiotech ٢٧ فبراير ٢٠٢٦ Earendil pens $885M pact to use WuXi XDC's linker tech for next-gen ADCs
FierceBiotech ٢٧ فبراير ٢٠٢٦ As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
FierceBiotech ٢٧ فبراير ٢٠٢٦ 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
FierceBiotech ٢٦ فبراير ٢٠٢٦ Sarepta CEO Doug Ingram to retire after a decade of Duchenne breakthroughs and controversies
FierceBiotech ٢٦ فبراير ٢٠٢٦ Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial
FierceBiotech ٢٦ فبراير ٢٠٢٦ Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
FierceBiotech ٢٦ فبراير ٢٠٢٦ Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial
FierceBiotech ٢٦ فبراير ٢٠٢٦ Quantum Surgical snaps up J&J's NeuWave Medical for its microwave ablation technology
FierceBiotech ٢٦ فبراير ٢٠٢٦ Protagonist plans to pocket $400M from Takeda rather than split US rusfertide profits